Thus, inflammasome/pyroptosomes activation and cleavage of GSDMD and PANX1 are likely to induce pore formation leading to the “ballooning” morphology and the subsequent release of LDH and IL-1b seen in the drug treated myeloma cells. The gene discussed is PANX1; the disease is plasma cell myeloma.